At this time, posts about IGEN are rapidly increasing on portals and stock communities, and today, foreigners are tentatively estimated to have net purchased 5,859 shares. IGEN is known as a biopharmaceutical development company.


As of 1:30 PM on the 19th, IGEN's stock price is 17,400 KRW, down 2.25% from the previous day, with a trading volume of 492,821 shares, which is about 19.06% of the 5-day average trading volume. On March 17, IGEN became a market issue with the headline "mRNA COVID-19 vaccine development expectations... up 12%".


In addition to IGEN, posts by investors about Hanmi Pharm (128940), AhnLab (053800), and Robotis (108490) are also rapidly increasing.



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing